clinical services

The practice of medicine has long been shifting from the classical model of clinical care based on signs and symptoms to the application of biomarker guided decision making.

In a clinical setting, biomarkers can be classified as follows:

  • Preventative – identifying outwardly healthy people at a high risk of developing disease
  • Diagnostic – identify a disease at the earliest stage, before clinical symptoms occur
  • Prognostic – stratify the risk of disease progression in patients undergoing specific therapy
  • Predictive – identify patients who respond to specific therapeutic interventions
  • Therapeutic –provide a quantifiable measure of response in patients who undergo treatment

Affinity Biomarker Labs mission is to assist principal investigators and clinicians discover, validate and translate potentially lifesaving biomarkers in a robust, cost effective and timely manner.

Through a close working relationship with leading academics and teaching hospitals including King’s College Hospital, Imperial College, Guy’s and St Thomas’ and Newcastle University to name a few, Affinity Biomarker Labs is the ideal partner to support your clinical biomarker development program.